Thromb Haemost 1999; 81(04): 561-565
DOI: 10.1055/s-0037-1614524
Rapid Communication
Schattauer GmbH

Atherothrombogenic Risk Modulation by n-3 Fatty Acids Was not Associated with Changes in Homocysteine in Subjects with Combined Hyperlipidaemia

H. Grundt
1   From the Departments of Medicine, Stavanger, Norway
,
D. W. T. Nilsen
1   From the Departments of Medicine, Stavanger, Norway
,
Ø. Hetland
2   Clinical Chemistry, Central Hospital in Rogaland, Stavanger, Norway
,
M. A. Mansoor
2   Clinical Chemistry, Central Hospital in Rogaland, Stavanger, Norway
,
T. Aarsland
3   Hjertelaget Research Foundation, Stavanger, Norway
,
L. Woie
1   From the Departments of Medicine, Stavanger, Norway
› Author Affiliations
Further Information

Publication History

Publication Date:
09 December 2017 (online)

Preview

Summary

Favourable effects of n-3 fatty acids on the atherogenic risk profile were recently demonstrated in subjects with combined (type IIb) hyperlipidaemia, not responding to a therapeutic diet.

Re-examination of a previous patient material was performed to assess the influence of n-3 fatty acids on homocysteine and several coagulation factors.

Subjects were randomly allocated to receive either a concentrated compound of 85% eicosapentaenoic acid (EPA)/docosahexaenoic acid (DHA) (n = 28), or corn oil (n = 29), in a daily dose of 4 g for 12 weeks. The intervention was double-blind.

Homocysteine remained unchanged in both groups after 12-week treatment. N-3 fatty acids supplementation did not affect the levels of fibrinogen, coagulation factor VII or tissue factor pathway inhibitor (TFPI), while plasminogen activator inhibitor (PAI) increased significantly (Student’s t-test; p <0.05). Total blood platelets were significantly reduced in subjects receiving n-3 fatty acids (Student’s t-test; p <0.05), whereas bleeding times increased non-significantly.